Enhance patient access and engagement by utilizing today's digital technology

reSET

  • Adding reSET® to outpatient therapy significantly improved abstinence and retention of patients with substance use disorder1

  • Gain deeper insights into patients’ progress toward recovery with the Clinician Dashboard, allowing for more transparency in the patient-clinician dialogue1

  • Offers interactive treatment modules that deliver cognitive behavioral therapy, contingency management, and fluency learning to reinforce proficiency1

reSET-O

  • Adding reSET-O™ to outpatient treatment using buprenorphine increased retention of patients with opioid use disorder2

  • Follow patient-reported buprenorphine adherence with the Clinician Dashboard, allowing for more transparency in the patient-clinician dialogue2

  • Offers interactive treatment modules that deliver cognitive behavioral therapy, contingency management, and fluency learning to reinforce proficiency2

www.resetconnect.com

reSET Connect is available to support you and your patients

Prescribe reSET today and help your patients stay connected and supported throughout recovery

Download on the App Store Get it on Google Play
Download on the App Store Get it on Google Play

reSET Important Safety Information

Warnings: reSET is intended for patients whose primary language is English and who have access to an Android/iOS tablet or smartphone. reSET is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET to communicate to their clinician any urgent or emergent information. reSET is not to be used for emergencies. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET is not intended to be used as a stand-alone therapy for substance use disorder (SUD) and does not replace care by a licensed medical practitioner. reSET does not represent a substitution for a patient's medication. Patients should continue to take their medications as directed by their physician or medical provider.

The long-term benefit of treatment with reSET on abstinence has not been evaluated in studies lasting beyond 12 weeks in the Substance Use Disorder (SUD) population. The ability of reSET to prevent potential relapse after treatment discontinuation has not been studied.

Indications for Use

reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse.

It is intended to:

  • increase abstinence from a patient’s substances of abuse during treatment, and
  • increase retention in the outpatient treatment program.

Please see Clinician Brief Summary Instructions for reSET.

reSET-O Important Safety Information

Warnings: reSET-O is intended for patients whose primary language is English and who have access to an Android/iOS tablet or smartphone. reSET-O is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).

Clinicians should not use reSET-O to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET-O to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.

reSET-O is not intended to be used as a stand-alone therapy for Opioid Use Disorder (OUD). reSET-O does not replace care by a licensed medical practitioner. reSET-O does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider. The ability of reSET-O to prevent potential relapse after treatment discontinuation has not been studied.

Indications for Use

reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.

Limitations of Use

reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

Please see Clinician Brief Summary Instructions for reSET-O.

Important Safety Information